Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Y Morgan

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Gastroenterology|January 1, 1983
Hepatic iron uptake in alcoholic liver diseaseR W Chapman, M Y Morgan, R Bell, et al.
British Medical Journal|June 3, 1972
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancyJ E Pohl, H Thurston, D Davis, et al.
Gastroenterology|April 1, 1980
Successful use of bromocriptine in the treatment of chronic hepatic encephalopathyM Y Morgan, A W Jakobovits, I M James, et al.
Gut|December 1, 1982
Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trialA W Marshall, R S Graul, M Y Morgan, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre studyR Williams, O F James, T W Warnes, et al.
Gut|November 1, 1980
Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trialJ C Colman, M Y Morgan, P J Scheuer, et al.
British Journal of Addiction|March 1, 1987
Alcohol-related problems amongst selected hospital patients and the cost incurred in their careA Scheffler, A Fawcett, J Pushkin, et al.
Digestive Diseases and Sciences|April 1, 1983
Acute and chronic effects of alcohol on iron absorptionR W Chapman, M Y Morgan, A M Boss, et al.
Gut|May 1, 1982
Plasma amino-acid patterns in liver diseaseM Y Morgan, A W Marshall, J P Milsom, et al.
British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Gastroenterology|January 1, 1983
Hepatic iron uptake in alcoholic liver diseaseR W Chapman, M Y Morgan, R Bell, et al.
British Medical Journal|June 3, 1972
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancyJ E Pohl, H Thurston, D Davis, et al.
Gastroenterology|April 1, 1980
Successful use of bromocriptine in the treatment of chronic hepatic encephalopathyM Y Morgan, A W Jakobovits, I M James, et al.
Gut|December 1, 1982
Treatment of alcohol-related liver disease with thioctic acid: a six month randomised double-blind trialA W Marshall, R S Graul, M Y Morgan, et al.
European Journal of Gastroenterology & Hepatology|March 31, 2000
Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre studyR Williams, O F James, T W Warnes, et al.
Gut|November 1, 1980
Treatment of alcohol-related liver disease with (+)-cyanidanol-3: a randomised double-blind trialJ C Colman, M Y Morgan, P J Scheuer, et al.
British Journal of Addiction|March 1, 1987
Alcohol-related problems amongst selected hospital patients and the cost incurred in their careA Scheffler, A Fawcett, J Pushkin, et al.
Digestive Diseases and Sciences|April 1, 1983
Acute and chronic effects of alcohol on iron absorptionR W Chapman, M Y Morgan, A M Boss, et al.
Gut|May 1, 1982
Plasma amino-acid patterns in liver diseaseM Y Morgan, A W Marshall, J P Milsom, et al.
British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.
Pageof 10